Association between Alanine Aminotransferase/Aspartate Aminotransferase Ratio (AST/ALT Ratio) and Coronary Artery Injury in Children with Kawasaki Disease
Table 1
Demographic characteristics.
Low-AAR group
High-AAR group
value
Number
1287
1290
Age (month)
20.39 (11.85–35.77)
20.45 (9.99–38.83)
0.883
IVIG treat time (days)
6.00 (6.00–7.00)
7.00 (6.00–8.00)
<0.001
Sex
0.034
Male
821 (63.79%)
874 (67.75%)
Female
466 (36.21%)
416 (32.25%)
KD type
<0.001
Typical KD
1059 (82.28%)
883 (68.45%)
Atypical KD
228 (17.72%)
407 (31.55%)
Fever
1280 (99.46%)
1275 (98.84%)
0.088
Rash
1044 (81.12%)
905 (70.16%)
<0.001
Conjunctivitis
1189 (92.39%)
1041 (80.70%)
<0.001
Oral changes
1193 (92.70%)
1179 (91.40%)
0.222
Extremity changes
972 (75.52%)
900 (69.77%)
0.001
Lymph
635 (49.34%)
657 (50.93%)
0.419
IVIG treat
No use
43 (3.43%)
156 (12.29%)
2 g/kgday
1036 (82.62%)
974 (76.75%)
<0.001
1 g/kgday
175 (13.96%)
139 (10.95%)
Steroid
80 (6.24%)
60 (4.66%)
0.079
Results are given as (N) mean (SD) median (Q1–Q3)/N (%). KD: Kawasaki disease; AAR: aspartate aminotransferase (AST)/alanine aminotransferase (ALT) ratio; IVIG: intravenous immunoglobulin therapy.
